Max Healthcare Board to Consider Financial Results on November 14, 2025

The Board of Directors of Max Healthcare Institute Limited is scheduled to meet on Friday, November 14, 2025, to review and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. Trading window remains closed for designated persons until 48 hours after the declaration of results.

Financial Results Announcement

Max Healthcare has announced a board meeting to be held on November 14, 2025. During this meeting, the board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2025.

Trading Window Closure

In line with company policy, the trading window for securities remains closed for all designated individuals and their immediate relatives. This restriction will continue until 48 hours following the declaration of the company’s financial results.

Source: BSE

Previous Article

Concord Biotech Board to Approve Q2 & H1 Unaudited Financial Results

Next Article

Hexaware Acquires 100% Stake in IAAS and IT Glitterz

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *